Out For Tender › Vereinigte Staaten › Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte
Lumenis BE Stellar M22 Multi-Platform Laser System
- Auftraggeber
- DEFENSE HEALTH AGENCY, Dept of Defense
- Land
- Vereinigte Staaten
- Kategorie
- Medizinische Ausrüstungen, Arzneimittel und Körperpflegeprodukte
- Frist
- Endet heute (24 Sep 2026 09:00 UTC-4)
- Veröffentlicht
- 18 Sep 2026
- Verfahren
- Combined Synopsis/Solicitation - Service-Disabled Veteran-Owned Small Business (SDVOSB) Sole Source (FAR 19.14)
Offizielle Bekanntmachung lesen und bieten → Die Angebotsabgabe erfolgt immer auf dem Portal des Auftraggebers, niemals hier.
Was der Auftraggeber sucht
Solicitation Number: HT0014-26-Q-E054 Contracting Activity: Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - Northeast (HCD-NE) in support of the White House Medical Unit (WHMU). Title: Procurement of Two (2) Lumenis BE Stellar M22 Multi-Application Laser/IPL Platforms (Brand Name or Equal) Classification Code (PSC): 6515 Medical and Surgical Instruments, Equipment, and Supplies NAICS Code: 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing Small Business Size Standard: 1,250 Employees Set-Aside Status: 100% Total Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside Notice Type: Combined Synopsis / Solicitation Original Published Date: September 18, 2026 Response Date / Local Time: September 24, 2026, 09:00 (9:00 AM) Eastern Time Anticipated Award / Effective Date: September 30, 2026 1. GENERAL INFORMATION & DESCRIPTION This is a combined synopsis/solicitation for commercial products prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This acquisition is conducted under FAR Part 12 (Acquisition of Commercial Products and Commercial Services) and utilizes the simplified procedures authorized under FAR Subpart 13.5 (Simplified Procedures for Certain Commercial Items). This announcement constitutes the only solicitation; quotes are being requested and a separate written solicitation will not be issued. This acquisition is issued as a Request for Quotes (RFQ) under RFQ number HT0014-26-Q-E054. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01 / Defense Federal Acquisition Regulation Supplement (DFARS) current edition. This procurement is 100% Set-Aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) under NAICS code 334510 (size standard: 1,250 employees). Only businesses certified by the Small Business Administration (SBA) in the Veteran Small Business Certification (VetCert) program at the time of quote submission and award are eligible to compete. The Nonmanufacturer Rule (13 CFR 121.406 / FAR 52.219-33) applies. Quoters must provide an official, current letter signed by Lumenis Be, Inc. confirming that the offeror is an authorized distributor/reseller entitled to furnish the specified systems, provide genuine OEM parts, and guarantee full factory warranty and OEM-certified service backing. 2. CONTRACT LINE-ITEM NUMBER (CLIN) SCHEDULE The Government intends to award a single Firm-Fixed-Price (FFP) contract resulting from this solicitation. 3. SALIENT CHARACTERISTICS (FAR 52.211-6: BRAND NAME OR EQUAL) The White House Medical Unit requires two (2) multi-application dermatological laser/light console platforms to deliver advanced cutaneous, vascular, pigmented lesion, and skin resurfacing treatment. The baseline performance is established by the Lumenis BE Stellar M22 Platform System. Any offeror proposing an "Equal" product must provide technical documentation, engineering specifications, and descriptive literature verifying that the offered system satisfies every salient characteristic listed below: Salient Characteristics: Clinical performance Optical spectrum 400 to 1200 nm with interchangeable cut-off filters. Filters available: 515, 560, 590, 615, 640, 695, 755 nm, plus dual-band filters for acne and vascular presets Multiple Sequential Pulsing for controlled epidermal heating and vascular selectivity Fluence range with fine 0.5 to 1.0 J/cm² increments Pulse duration 2 to 20 ms with adjustable intra-pulse delay 5 to 150 ms to enable subpulsing. Sapphire lightguides with verified coupling and spot sizes: 8 × 15 mm, 15 × 35 mm, and 6 mm round. 850+ Preset protocols by indication and skin type Patient safety and comfort Sapphire contact cooling at >10 degrees Interlocks, error prompts, and SW safety Compatibility with periocular…
Sprache dieser Bekanntmachung: English. Titel und Beschreibung erscheinen genau so, wie der Auftraggeber sie veröffentlicht hat.
Source: SAM · reference HT0014-26-Q-E054 · JSON